Plus Therapeutics Investor Relations Material
Latest events
Business Update
Plus Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Plus Therapeutics Inc
Access all reports
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative therapies for rare cancers. The company leverages nanotechnology and targeted drug delivery platforms to design precision treatments, including radiotherapeutics for central nervous system cancers and other challenging oncological conditions. The company is headquartered in Austin, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
PSTV
Country
🇺🇸 United States